Thalidomide and dexamethasone: a new standard of care for initial therapy in multiple myeloma

MeSH terms

• Antineoplastic Combined Chemotherapy Protocols / adverse effects
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Clinical Trials, Phase III as Topic
• Dexamethasone / administration & dosage*
• Dexamethasone / pharmacology
• Doxorubicin / administration & dosage
• Drug Synergism
• Humans
• Multicenter Studies as Topic
• Multiple Myeloma / drug therapy*
• Multiple Myeloma / metabolism
• Randomized Controlled Trials as Topic
• Remission Induction
• Thalidomide / administration & dosage*
• Thalidomide / pharmacology
• Treatment Outcome
• Vincristine / administration & dosage